Hyun-Ja Ko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hyun-Ja Ko has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Kwang Soon Kim
Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea
2 shared publications - Minji Lee
Research Institute of NeoImmuneTech, Co., Ltd, Pohang, Korea (the Republic of)
2 shared publications - Sung-Wook Hong
Department of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
2 shared publications - Andrew M. Lew
The Walter & Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
1 shared publication - Balasubramanian Krishnamurthy
Immunology and Diabetes Unit, St Vincent’s Institute , Fitzroy, Victoria
1 shared publication Ban-Hock Toh
Department of Immunology, Monash Central Clinical School, and ‡Centre for Inflammatory Diseases, Department of Medicine, Southern Clinical School, Monash University, Victoria, Australia
1 shared publication
Latest Publications
- Open Access
- 6 May 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-10
Dietary antigens suppress the proliferation of type 2 innate lymphoid cells by restraining homeostatic IL-25 production
Dietary antigens affect the adaptive immunity of the host by inducing regulatory T cells and IgE-producing B cells. However, their roles in innate immune compartments such as innate lymphoid cells (ILCs) and intestinal epithelial cells (IECs) are unclear. Here, using antigen-free (AF) mice, which are germ-free (GF) mice fed with amino-acid-based diet, we found dietary proteins suppress the development of GATA-3-expressing ILC2s independent of the adaptive immune cells. These cells produce more type 2 cytokines and upregulated proliferation and activation markers such as Ki-67, CD69, and CD25. With this, AF mice had increased expressions of tuft cell-specific transcripts such as Il25, Il33, Dclk1, Trpm5, and Pou2f3 in IECs. Accordingly, expanded ILC2s upregulated IL-17RB, a receptor of IL-25, and their proliferation was blocked by IL-25 neutralizing or IL-17RB blocking antibodies. These results suggest a new dialogue between dietary antigens, IECs, and ILCs in which dietary antigens suppress ILC2 activation and proliferation by restraining homeostatic IL-25 production, potentially limiting type 2 immunity by food antigens.
- 6 May 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-10
Open AccessDietary antigens suppress the proliferation of type 2 innate lymphoid cells by restraining homeostatic IL-25 production
Dietary antigens affect the adaptive immunity of the host by inducing regulatory T cells and IgE-producing B cells. However, their roles in innate immune compartments such as innate lymphoid cells (ILCs) and intestinal epithelial cells (IECs) are unclear. Here, using antigen-free (AF) mice, which are germ-free (GF) mice fed with amino-acid-based diet, we found dietary proteins suppress the development of GATA-3-expressing ILC2s independent of the adaptive immune cells. These cells produce more type 2 cytokines and upregulated proliferation and activation markers such as Ki-67, CD69, and CD25. With this, AF mice had increased expressions of tuft cell-specific transcripts such as Il25, Il33, Dclk1, Trpm5, and Pou2f3 in IECs. Accordingly, expanded ILC2s upregulated IL-17RB, a receptor of IL-25, and their proliferation was blocked by IL-25 neutralizing or IL-17RB blocking antibodies. These results suggest a new dialogue between dietary antigens, IECs, and ILCs in which dietary antigens suppress ILC2 activation and proliferation by restraining homeostatic IL-25 production, potentially limiting type 2 immunity by food antigens.
- Open Access
- 3 May 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (5) , eaaw1507
Food antigens drive spontaneous IgE elevation in the absence of commensal microbiota
Immunoglobulin E (IgE), a key mediator in allergic diseases, is spontaneously elevated in mice with disrupted commensal microbiota such as germ-free (GF) and antibiotics-treated mice. However, the underlying mechanisms for aberrant IgE elevation are still unclear. Here, we demonstrate that food antigens drive spontaneous IgE elevation in GF and antibiotics-treated mice by generating T helper 2 (TH2)–skewed T follicular helper (TFH) cells in gut-associated lymphoid tissues (GALTs). In these mice, depriving contact with food antigens results in defective IgE elevation as well as impaired generation of TFH cells and IgE-producing cells in GALT. Food antigen–driven TFH cells in GF mice are mostly generated in early life, especially during the weaning period. We also reveal that food antigen–driven TFH cells in GF mice are actively depleted by colonization with commensal microbiota. Thus, our findings provide a possible explanation for why the perturbation of commensal microbiota in early life increases the occurrence of allergic diseases.
- 3 May 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (5) , eaaw1507
Open AccessFood antigens drive spontaneous IgE elevation in the absence of commensal microbiota
Immunoglobulin E (IgE), a key mediator in allergic diseases, is spontaneously elevated in mice with disrupted commensal microbiota such as germ-free (GF) and antibiotics-treated mice. However, the underlying mechanisms for aberrant IgE elevation are still unclear. Here, we demonstrate that food antigens drive spontaneous IgE elevation in GF and antibiotics-treated mice by generating T helper 2 (TH2)–skewed T follicular helper (TFH) cells in gut-associated lymphoid tissues (GALTs). In these mice, depriving contact with food antigens results in defective IgE elevation as well as impaired generation of TFH cells and IgE-producing cells in GALT. Food antigen–driven TFH cells in GF mice are mostly generated in early life, especially during the weaning period. We also reveal that food antigen–driven TFH cells in GF mice are actively depleted by colonization with commensal microbiota. Thus, our findings provide a possible explanation for why the perturbation of commensal microbiota in early life increases the occurrence of allergic diseases.
- 29 April 2014
- Published by Wiley in Immunology & Cell Biology
- Vol. 92 (7) , 640-644
Functional cytotoxic T lymphocytes against IGRP206‐214 predict diabetes in the non‐obese diabetic mouse
CD8+ T cells are prominent in autoimmune diabetes of both humans and non‐obese diabetic (NOD) mice. For example, CD8+ T cells against islet‐specific glucose 6‐phosphatase catalytic subunit‐related protein (IGRP) can be detected readily in older NOD mice. It has been suggested that the enumeration of islet‐specific CD8+ T cells in the peripheral blood may be a predictive biomarker for autoimmune type 1 diabetes (T1D). Here, we determined the natural history of the functional endogenous IGRP206–214‐specific cytotoxic T lymphocytes (CTLs) in NOD mice with regard to age (3‐ to 15‐week‐old pre‐diabetic mice and diabetic mice) and sex. We demonstrated that in vivo IGRP206–214‐specific CTLs significantly increased after 12 weeks of age and in vivo cytotoxicity in female NOD mice was significantly higher than in male NOD mice. To determine the in vivo IGRP206–214‐specific CTL frequency without killing the mice, we performed splenectomies on a cohort of mice after injecting IGRP206–214‐coated targets and then followed their diabetes progression. We found that CTL frequency correlated with future of disease onset. Thus, our data support that IGRP206–214‐specific CTLs may be a potent biomarker for T1D.
- 29 April 2014
- Published by Wiley in Immunology & Cell Biology
- Vol. 92 (7) , 640-644
Functional cytotoxic T lymphocytes against IGRP206‐214 predict diabetes in the non‐obese diabetic mouse
CD8+ T cells are prominent in autoimmune diabetes of both humans and non‐obese diabetic (NOD) mice. For example, CD8+ T cells against islet‐specific glucose 6‐phosphatase catalytic subunit‐related protein (IGRP) can be detected readily in older NOD mice. It has been suggested that the enumeration of islet‐specific CD8+ T cells in the peripheral blood may be a predictive biomarker for autoimmune type 1 diabetes (T1D). Here, we determined the natural history of the functional endogenous IGRP206–214‐specific cytotoxic T lymphocytes (CTLs) in NOD mice with regard to age (3‐ to 15‐week‐old pre‐diabetic mice and diabetic mice) and sex. We demonstrated that in vivo IGRP206–214‐specific CTLs significantly increased after 12 weeks of age and in vivo cytotoxicity in female NOD mice was significantly higher than in male NOD mice. To determine the in vivo IGRP206–214‐specific CTL frequency without killing the mice, we performed splenectomies on a cohort of mice after injecting IGRP206–214‐coated targets and then followed their diabetes progression. We found that CTL frequency correlated with future of disease onset. Thus, our data support that IGRP206–214‐specific CTLs may be a potent biomarker for T1D.
- 13 July 2011
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 8 (5) , 1488-1494
Hematopoietic Stem Cell Gene Therapy as a Treatment for Autoimmune Diseases
A key function of the immune system is to protect us from foreign pathogens such as viruses, bacteria, fungi and multicellular parasites. However, it is also important in many other aspects of human health such as cancer surveillance, tissue transplantation, allergy and autoimmune disease. Autoimmunity can be defined as a chronic immune response that targets self-antigens leading to tissue pathology and clinical disease. Autoimmune diseases, as a group of diseases that include type 1 diabetes, multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus, have no effective cures, and treatment is often based on long-term broad-spectrum immunosuppressive regimes. While a number of strategies aimed at providing disease specific treatments are being explored, one avenue of study involves the use of hematopoietic stem cells to promote tolerance. In this manuscript, we will review the literature in this area but in particular examine the relatively new experimental field of gene therapy and hematopoietic stem cell transplantation as a molecular therapeutic strategy to combat autoimmune disease.
- 13 July 2011
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 8 (5) , 1488-1494
Hematopoietic Stem Cell Gene Therapy as a Treatment for Autoimmune Diseases
A key function of the immune system is to protect us from foreign pathogens such as viruses, bacteria, fungi and multicellular parasites. However, it is also important in many other aspects of human health such as cancer surveillance, tissue transplantation, allergy and autoimmune disease. Autoimmunity can be defined as a chronic immune response that targets self-antigens leading to tissue pathology and clinical disease. Autoimmune diseases, as a group of diseases that include type 1 diabetes, multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus, have no effective cures, and treatment is often based on long-term broad-spectrum immunosuppressive regimes. While a number of strategies aimed at providing disease specific treatments are being explored, one avenue of study involves the use of hematopoietic stem cells to promote tolerance. In this manuscript, we will review the literature in this area but in particular examine the relatively new experimental field of gene therapy and hematopoietic stem cell transplantation as a molecular therapeutic strategy to combat autoimmune disease.